Cooper Companies (COO) Stock Price, News & Analysis

Company Overview

Cooper Companies, Inc. (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories. Its portfolio includes single‐use, multifocal, toric and specialty lenses for presbyopia and astigmatism, supported by proprietary materials and manufacturing technologies. CooperSurgical focuses on women’s health and fertility solutions, offering products such as surgical instruments, diagnostic devices, and assisted reproductive technology tools designed for obstetrics, gynecology and fertility clinics.

With a presence in over 100 countries, CooperCompanies serves markets across North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The company maintains manufacturing facilities and R&D centers in key regions, enabling close collaboration with healthcare professionals and customers to address evolving medical and patient needs.

CooperCompanies is guided by an experienced leadership team and board of directors committed to innovation, quality and compliance. Through ongoing investment in research and development, the company aims to expand its product offerings, enhance clinical outcomes and support the global healthcare community.

Key Stats

• Today's Range: $70.71 to $72.47
• 50-Day Range: $64.32 to $75.22
• 52-Week Range: $61.78 to $109.04
• Volume: 2.37 million shs
• Average Volume: 2.97 million shs
• Market Capitalization: $14.31 billion
• P/E Ratio: 35.45
• Dividend Yield: N/A
• Price Target: $84.77
• Consensus Rating: Moderate Buy

Cooper Companies Stock Analysis - MarketRank™

Cooper Companies scored higher than 73% of companies evaluated by MarketBeat, and ranked 293rd out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Cooper Companies has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 10 buy ratings, 3 hold ratings, and 1 sell rating.

Upside Potential

Cooper Companies has a consensus price target of $84.77, representing about 17.8% upside from its current price of $71.97.

Amount of Analyst Coverage

Cooper Companies has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 11.81%

Earnings Growth

Earnings for Cooper Companies are expected to grow by 11.81% in the coming year, from $3.98 to $4.45 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cooper Companies is 35.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 230.71.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cooper Companies is 35.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 84.52.

Price to Earnings Growth Ratio

Cooper Companies has a PEG Ratio of 1.88. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Cooper Companies has a P/B Ratio of 1.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.87% of the outstanding shares of Cooper Companies have been sold short.

Short Interest Ratio / Days to Cover

Cooper Companies has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cooper Companies has recently increased by 23.24%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cooper Companies does not currently pay a dividend.

Dividend Growth

Cooper Companies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.87% of the outstanding shares of Cooper Companies have been sold short.

Short Interest Ratio / Days to Cover

Cooper Companies has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cooper Companies has recently increased by 23.24%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.80

News Sentiment

Cooper Companies has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 22 news articles for Cooper Companies this week, compared to 22 articles on an average week.

Search Interest

Only 16 people have searched for COO on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

MarketBeat Follows

5 people have added Cooper Companies to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Cooper Companies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,216,346.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.98% of the stock of Cooper Companies is held by insiders.

Percentage Held by Institutions

Only 24.39% of the stock of Cooper Companies is held by institutions.

COO Stock Analysis - Frequently Asked Questions

How have COO shares performed this year?

Cooper Companies' stock was trading at $91.93 at the beginning of 2025. Since then, COO stock has decreased by 21.7% and is now trading at $71.97.

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NASDAQ:COO) released its quarterly earnings results on Wednesday, August, 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. The firm's quarterly revenue was up 5.7% on a year-over-year basis.
Read the conference call transcript.

When did Cooper Companies' stock split?

Cooper Companies shares split on Tuesday, February 20th 2024.The 4-1 split was announced on Tuesday, February 20th 2024. The newly minted shares were distributed to shareholders after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

Is Cooper Companies buying back stock?

Cooper Companies' board initiated a stock buyback plan on Wednesday, September 17th 2025, which authorizes the company to buy back $2,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 15.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's management believes its shares are undervalued.

Does Cooper Companies have any subsidiaries?

Cooper Companies subsidiaries include these companies: Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., Coopervision, CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, and others.

Who are Cooper Companies' major shareholders?

Cooper Companies' top institutional investors include Boston Trust Walden Corp (0.75%), Swedbank AB (0.45%), Congress Asset Management Co. (0.23%) and Voya Investment Management LLC (0.07%). Insiders that own company stock include Robert S Weiss, Albert G White III, Daniel G Mcbride, Jody S Lindell, Brian G Andrews, Gerard H Warner III, Lawrence Erik Kurzius, Gary S Petersmeyer and Agostino Ricupati.
View institutional ownership trends.

How do I buy shares of Cooper Companies?

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cooper Companies investors own include NVIDIA (NVDA), Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

• Last Earnings: 8/27/2025
• Today: 10/17/2025
• Fiscal Year End: 10/31/2025
• Next Earnings (Estimated): 12/04/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:COO
• Previous Symbol: NYSE:COO
• CIK: 711404
• Web: www.coopercos.com
• Phone: (925) 460-3600
• Fax: 925-460-3649
• Employees: 16,000
• Year Founded: 1958

Price Target and Rating

• Average Price Target for Cooper Companies: $84.77
• High Price Target: $110.00
• Low Price Target: $64.00
• Potential Upside/Downside: +17.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.73
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.03
• Trailing P/E Ratio: 35.45
• Forward P/E Ratio: 18.08
• P/E Growth: 1.88
• Net Income: $392.30 million
• Net Margins: 10.08%
• Pretax Margin: 15.28%
• Return on Equity: 9.82%
• Return on Assets: 6.54%

Debt

• Debt-to-Equity Ratio: 0.29
• Current Ratio: 2.12
• Quick Ratio: 1.24

Sales & Book Value

• Annual Sales: $3.90 billion
• Price / Sales: 3.67
• Cash Flow: $5.62 per share
• Price / Cash Flow: 12.80
• Book Value: $40.50 per share
• Price / Book: 1.78

Miscellaneous

• Outstanding Shares: 198,810,000
• Free Float: 194,873,000
• Market Cap: $14.31 billion
• Optionable: Optionable
• Beta: 1.02